Regenacy Pharmaceuticals is developing a novel, disease-modifying approach to treating peripheral neuropathies that goes beyond pain and symptom management to restore peripheral nerve function.
Our lead compound ricolinostat (ACY-1215) is an oral, selective inhibitor of the microtubule modifying enzyme HDAC6 with first-in-class potential, currently positioned to enter Phase 2 clinical trials. Our investigation of ricolinostat for diabetic, chemotherapy-induced and inherited peripheral neuropathies is based on compelling proof-of-concept preclinical studies demonstrating restoration of normal nerve function.
We were founded in December 2016 following the acquisition of Acetylon Pharmaceuticals by Celgene. Regenacy received exclusive rights to ricolinostat, a clinical stage, orally bioavailable, HDAC6 selective inhibitor, for a range of non-cancer disease indications. We also have a unique and proprietary portfolio of selective HDAC1,2 inhibitors with potential for treating cancer, hemoglobinopathies, and cognitive dysfunction.
Company Details
- Employees
- 6
- Founded
- 2016
- Address
- 303 Wyman St, Waltham,massachusetts 02451,united States
- Phone
- (617) 415-5030
- in****@****acy.com
- Industry
- Biotechnology
- Website
- regenacy.com
- HQ
- Waltham, Massachusetts
Regenacy Pharmaceuticals, Inc. Questions
Regenacy Pharmaceuticals, Inc.'s helpline number is (617) 415-5030
Regenacy Pharmaceuticals, Inc.'s website is regenacy.com
Regenacy Pharmaceuticals, Inc.'s LinkedIn profile is https://www.linkedin.com/company/regenacy-pharmaceuticals
Regenacy Pharmaceuticals, Inc. has
6 employees.
View email and phone details for 6
employees at Regenacy Pharmaceuticals, Inc..
Regenacy Pharmaceuticals, Inc.'s industry is
Biotechnology
Regenacy Pharmaceuticals, Inc.'s top competitors are
Clintricare Gmbh,
Max Planck Mental Health Collective,
Revere Pharmaceuticals,
Gsk,
Ark Medical Solutions Inc.,
Syner-G Biopharma Group,
Skyhawk Therapeutics,
Blue Hills Therapeutics Inc.,
Ionis Pharmaceuticals, Inc.,
Beam Therapeutics.
Regenacy Pharmaceuticals, Inc.'s support email address is info@regenacy.com
Regenacy Pharmaceuticals, Inc.'s categories are Biotechnology
Regenacy Pharmaceuticals, Inc.'s founding year is 2016
